ORASURE TECHNOLOGIES INC (OSUR)

Company Profile

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. The company is headquartered in Bethlehem, Pennsylvania and currently employs 840 full-time employees. The firm operates through two segments: the Diagnostics segment and the Molecular Solutions segment. The Diagnostics business primarily consists of the development, manufacture, marketing, and sale of simple, easy-to-use diagnostic products and specimen collection devices using its proprietary technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Molecular Solutions business is operated by Company's subsidiaries, DNA Genotek, Diversigen, and Novosanis. The Molecular Solutions segment products primarily consist of collection kits and services used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.

Company Info

ORASURE TECHNOLOGIES INC

220 E First St

Bethlehem PENNSYLVANIA 18015

P: 15036416115

CEO: Stephen S. Tang

Employees: 840

Website: https://www.orasure.com/